Information card for entry 2312373
Common name |
cilnidipine |
Chemical name |
(rac)-3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylate |
Formula |
C27 H28 N2 O7 |
Calculated formula |
C27 H28 N2 O7 |
Title of publication |
High-throughput nanoscale crystallization of dihydropyridine active pharmaceutical ingredients. |
Authors of publication |
Metherall, Jessica P.; Corner, Philip A.; McCabe, James F.; Hall, Michael J.; Probert, Michael R. |
Journal of publication |
Acta crystallographica Section B, Structural science, crystal engineering and materials |
Year of publication |
2024 |
Journal volume |
80 |
Journal issue |
1 |
Pages of publication |
4 - 12 |
a |
15.0989 ± 0.0017 Å |
b |
59.567 ± 0.007 Å |
c |
10.954 ± 0.0012 Å |
α |
90° |
β |
90° |
γ |
90° |
Cell volume |
9852 ± 1.9 Å3 |
Cell temperature |
100 K |
Ambient diffraction temperature |
100 K |
Number of distinct elements |
4 |
Space group number |
43 |
Hermann-Mauguin space group symbol |
F d d 2 |
Hall space group symbol |
F 2 -2d |
Residual factor for all reflections |
0.0458 |
Residual factor for significantly intense reflections |
0.0398 |
Weighted residual factors for significantly intense reflections |
0.0915 |
Weighted residual factors for all reflections included in the refinement |
0.0936 |
Goodness-of-fit parameter for all reflections included in the refinement |
0.986 |
Diffraction radiation probe |
x-ray |
Diffraction radiation wavelength |
0.6889 Å |
Diffraction radiation type |
Synchrotron |
Has coordinates |
Yes |
Has disorder |
No |
Has Fobs |
Yes |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/2312373.html